Interleukin 1 beta (IL-1β) promoter C [-511] T polymorphism but not C [+3953] T polymorphism is associated with polycystic ovary syndrome

被引:26
作者
Mu, Yuan [2 ,3 ]
Liu, Jingjing [1 ]
Wang, Binbin [2 ,3 ]
Wen, Qiaolian [2 ,3 ]
Wang, Jing [2 ,3 ]
Yan, Jinting [2 ,3 ]
Zhou, Sirui [2 ,3 ]
Ma, Xu [2 ,3 ,4 ]
Cao, Yunxia [1 ]
机构
[1] Anhui Med Univ, Reprod Med Ctr, Affiliated Hosp 1, Hefei, Peoples R China
[2] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China
[3] Natl Res Inst Family Planning, Ctr Genet, Beijing 100081, Peoples R China
[4] WHO, Collaborating Ctr Res Human Reprod, Beijing, Peoples R China
关键词
Polycystic ovary syndrome; Polymorphism; Interleukin; 1; beta; GENE POLYMORPHISM; GASTRIC-CANCER; INSULIN; INDOMETHACIN; OVULATION; WOMEN;
D O I
10.1007/s12020-009-9268-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PCOS is a complex multifactorial disorder involving a number of genetic and environmental factors. One of the genetic factors that has been associated with PCOS is Interleukin 1 beta (IL-1 beta), is an important inflammatory cytokine that plays a regulatory role in both the body's immune and the inflammatory responses. All these responses appear to be are also affected in at least some women with PCOS. To investigate the possible association of polymorphisms of the IL-1 beta gene with the occurrence and clinical characteristics of PCOS, we evaluated two common polymorphisms of the IL-1 beta gene (promoter C [-511] T and exon 5 position [+3953]) in 200 Chinese women with PCOS and 177 healthy Chinese controls. We found the frequency of IL-1 beta C/C [-511] genotype in PCOS was significantly higher than that in the controls (chi(2) = 15.48, df = 1, P < 0.001 OR = 2.73 95% CI: 1.64-4.56 by genotype; chi(2) = 10.21, df = 1, P = 0.001 by allele). However in contrast, no association between genotype and relative allele frequencies was observed for the C [+3953] T polymorphism for Chinese women with PCOS when compared to that for a similar group of Chinese women without PCOS (P = 0.35).
引用
收藏
页码:71 / 75
页数:5
相关论文
共 24 条
[1]   Insulin, androgens, and obesity in women with and without polycystic ovary syndrome:: a heterogeneous group of disorders [J].
Acién, P ;
Quereda, F ;
Matallín, P ;
Villarroya, E ;
López-Fernández, JA ;
Acién, M ;
Mauri, M ;
Alfayate, R .
FERTILITY AND STERILITY, 1999, 72 (01) :32-40
[2]  
AINSWORTH L, 1979, BIOL REPROD, V31, P115
[3]   The genetics of polycystic ovary syndrome [J].
Amato, P ;
Simpson, JL .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2004, 18 (05) :707-718
[4]   INHIBITORY EFFECT OF MIFEPRISTONE (RU-486) ON OVULATION IN THE ISOLATED-PERFUSED RAT OVARY [J].
BRANNSTROM, M .
CONTRACEPTION, 1993, 48 (04) :393-402
[5]   Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context [J].
Chen, HM ;
Wilkins, LM ;
Aziz, N ;
Cannings, C ;
Wyllie, DH ;
Bingle, C ;
Rogus, J ;
Beck, JD ;
Offenbacher, S ;
Cork, MJ ;
Rafie-Kolpin, M ;
Hsieh, CM ;
Kornman, KS ;
Duff, GW .
HUMAN MOLECULAR GENETICS, 2006, 15 (04) :519-529
[6]   Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1β [J].
Davis, BJ ;
Lennard, DE ;
Lee, CA ;
Tiano, HF ;
Morham, SG ;
Wetsel, WC ;
Langenbach, R .
ENDOCRINOLOGY, 1999, 140 (06) :2685-2695
[7]   Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development [J].
DelosSantos, MJ ;
Mercader, A ;
Frances, A ;
Portoles, E ;
Remohi, J ;
Pellicer, A ;
Simon, C .
BIOLOGY OF REPRODUCTION, 1996, 54 (03) :563-574
[8]   Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth [J].
Diamanti-Kandarakis, E ;
Piperi, C .
HUMAN REPRODUCTION UPDATE, 2005, 11 (06) :631-643
[9]   Indices of low-grade inflammation in polycystic ovary syndrome [J].
Diamanti-Kandarakis, Evanthia ;
Paterakis, Thomas ;
Kandarakis, Helen A. .
WOMEN'S HEALTH AND DISEASE: GYNECOLOGIC, ENDOCRINE, AND REPRODUCTIVE ISSUES, 2006, 1092 :175-186
[10]   Interleukin-1 polymorphisms associated with increased risk of gastric cancer [J].
El-Omar, EM ;
Carrington, M ;
Chow, WH ;
McColl, KEL ;
Bream, JH ;
Young, HA ;
Herrera, J ;
Lissowska, J ;
Yuan, CC ;
Rothman, N ;
Lanyon, G ;
Martin, M ;
Fraumeni, JF ;
Rabkin, CS .
NATURE, 2000, 404 (6776) :398-402